Carbon Health is a tech-enabled healthcare company founded in 2015 and headquartered in San Francisco, California. It provides a mobile application that facilitates primary care services, allowing users to manage their treatment plans, prescriptions, and lab reports in one place. The company offers omnichannel care through various access points, including clinics, pop-up sites, video consultations, and its application, ensuring convenient and accessible healthcare for patients. Additionally, Carbon Health developed a coronavirus assessment tool and has established COVID-19 testing sites in California, further enhancing its commitment to delivering comprehensive healthcare services.
Operator of a consumer health company intended to provide men with content, community, and clinical support to optimize them in mind and body. The company provides at-home lab tests and treatment, online group health coaching for nutrition, exercise, sleep, and focus, and also offers telemedicine and mail-order pharmacy services, enabling men to optimize their hormones and health.
Osmind Inc. specializes in developing healthcare software tailored for mental health providers and their patients, particularly focusing on treatment-resistant mental health conditions. Founded in 2020 and based in California, the company aims to enhance clinical care and streamline workflows for providers through its innovative software solutions. Osmind's tools not only facilitate improved patient care but also support the advancement of novel therapeutics, precision diagnostics, and care management programs. The company's mission is to increase patient access to effective mental health treatments that can succeed where traditional therapies may not.
Octant, Inc. engages in engineering biology to design multi-targeted small molecule drug leads for complex diseases. Its polypharmacology discovery engine generates multi-receptor pathway data and predictive insights to inform rational drug design. The company also engineers biology using living cells as high-throughput signal networks to map, measure, and model chemical structures against G protein-coupled receptors (GPCRs). The company was incorporated in 2017 and is headquartered in Los Angeles, California.
Octant, Inc. engages in engineering biology to design multi-targeted small molecule drug leads for complex diseases. Its polypharmacology discovery engine generates multi-receptor pathway data and predictive insights to inform rational drug design. The company also engineers biology using living cells as high-throughput signal networks to map, measure, and model chemical structures against G protein-coupled receptors (GPCRs). The company was incorporated in 2017 and is headquartered in Los Angeles, California.
Levels Health Inc. is a New York-based company that specializes in health and wellness through its innovative biowearable device utilizing continuous glucose monitoring (CGM) technology. Founded in 2019, Levels offers a platform that tracks real-time blood glucose levels, allowing consumers to understand how their diet and exercise affect their metabolic health. Through its online application, the company provides users with actionable feedback to optimize their lifestyle choices for better metabolic fitness. As a remote-first organization, Levels aims to empower individuals to take charge of their health by leveraging technology to monitor and improve their metabolic well-being.
Centenara Labs is a biotechnology company that focuses on developing innovative drug therapies aimed at improving and prolonging human lifespan. Founded in 2019 and headquartered in Zug, Switzerland, the company invests in research and technologies that target age-related diseases. Centenara Labs operates as a fully integrated platform, providing a range of services including drug discovery expertise, financial support, and administrative services. Its mission is to advance scientific understanding and create effective solutions that enable individuals to experience healthier and longer lives.
PairTree engages in modernizing the adoption process. It uses future-forward technology to connect adoptive parents with birth moms.
Kindbody operates a health and tech company intended to offer fertility services and treatments for the modern woman. It offers a full range of services including intrauterine insemination, in-vitro fertilization, donor support, egg freezing, and embryo freezing, enabling women to improve their overall health and wellbeing.
HealthRhythms makes it easy to measure and care for everyone’s mental health. By seamlessly gathering data about everyday behaviors and routines (our “behavioral rhythms”), HealthRhythms provides a more comprehensive and clinically grounded understanding of mental wellbeing. Our solution leverages deep machine learning and predictive analytics to create novel health assessments and just-in-time personalized interventions that improve the care delivery experience for patients, health plans, payers and research organizations. HealthRhythms was founded by a unique team of mental health care pioneers and information scientists at the forefront of health sensing.
Alto is a full-service pharmacy powered by a team of experts dedicated to making your doctor's orders their own. From delivering prescriptions to coordinating with insurance, digging for discounts, and answering, Alto works behind-the-scenes to remove any obstacles standing in the way of your care. The company started in 2015 and is headquartered in San Francisco, California.
Mightier is a gaming platform and family program scientifically-proven to help kids regulate their emotions. It is a bioresponsive program that harnesses the mind-body connection to build emotional regulation in its players. Its program of bioresponsive video games, developed at Boston Children's Hospital and Harvard Medical School, aims to help children with behavioral and emotional challenges learn how to harness emotions in daily life. Mightier was founded in 2016 and is headquartered in Boston, Massachusetts.
Developer of a behavioral health engagement platform intended to improve behavioral healthcare for underserved populations. The company's platform provides personalized care delivery services to integrate patients, providers and prescribers in the care cycle to manage the practice, enabling medical community to improve patient outcomes at minimal costs.
Bionaut Labs, Inc. designs, manufactures and controls the first intra- tissue navigation platform, using Bionaut nano/micro robots operating inside the body. The company offers a delivery mechanism which is anatomically precise by design. The company was founded in 2016 and is headquartered in Palo Alto, California.
Blackrock Neurotech’s mission is to provide innovative tools and neurotech expertise to translate technology into a novel, implantable clinical solutions that improve human lives.
Jane Technologies, Inc. is a retail tech company that has created iheartjane.com — the cannabis industry’s only complete online marketplace, providing consumers with a confident, safe and simple shopping experience. Users can browse local products in real-time, compare by price, proximity or popularity and place orders at local stores for free. Jane partners with dispensaries on a win-win basis; stores only pay for completed orders at a fraction of the price of other industry software.
MiResource is focused on enhancing mental health accessibility by connecting individuals, particularly young people, with licensed mental healthcare providers. The company has developed a platform that organizes and updates information about in-network therapy providers, ensuring that patients can easily find and access effective talk therapies and counseling sessions. By streamlining the connection between health systems and mental health resources, MiResource aims to create a more mentally healthy society.
Beckley Psytech Limited manufactures psychedelic drug for treating psychiatric and neurological diseases. Beckley Psytech Limited was formerly known as Beckley Psychedelics Limited and changed its name to Beckley Psytech Limited in May 2020. The company was founded in 2014 and is based in Oxford, United Kingdom.
Paradromics, Inc. is focused on developing brain-machine interfaces that facilitate data transmission between the brain and machines, primarily targeting the treatment of neurodegenerative diseases. The company creates implantable systems capable of decoding complex neural recordings into data streams, which can be utilized by various neural prostheses. Its technology emphasizes high-volume, bidirectional data streaming, allowing patients with neurological disorders to reconnect with their environment and compensate for lost biological connectivity. Founded in 2015 and headquartered in Austin, Texas, Paradromics also offers applications to support its product suite, aiming to enhance the quality of life for individuals with disabilities.
Woebot Health is a San Francisco-based company founded in 2017 that specializes in developing mental health chatbot applications. Its primary mission is to make mental health care widely accessible through innovative technology. The company's chatbot engages users in conversation, providing tailored responses to help reduce symptoms of mood-based disorders. By combining effective therapeutic techniques with advanced digital tools, Woebot Health offers a suite of digital therapeutics and behavioral health products designed to be responsive and targeted to individual needs. The company has received funding from several venture capital firms, including New Enterprise Associates, Jazz Venture Partners, and Social Discovery Ventures, as well as contributions from Andrew Ng's AI Fund.
Many pharmaceutical drugs originate from nature due to intrinsic biodiversity, biological activity, and safety that has been optimized throughout time. A shift towards natural products is evident from significant interest and clinical data identifying cannabis and psychedelics as emerging therapeutics. Psilera will leverage its research strength being lead by executives from the pharmaceutical and cannabis industries to develop a best-in-class IP portfolio of analogues based on psychoactive precursors. Lead compounds are formulated and screened against neurological targets to evaluate clinical potential with pipeline candidates in the areas of mood disorders, cognitive diseases, and addiction. Psilera’s mission is to make a significant impact on mental health and reduce human suffering.
TRIPP Inc. is a company that specializes in developing virtual reality experiences aimed at enhancing emotional well-being. Founded in 2016 and headquartered in Los Angeles, California, with a development office in Chicago, TRIPP combines audio-visual elements, gameplay mechanics, and meditation to create immersive experiences that positively influence mood and mental states. Drawing on research indicating that interactive digital experiences can affect brain function, TRIPP positions itself as a pioneer in the intersection of gaming and mindfulness. By leveraging their expertise in game design, the company seeks to redefine the traditional notion of gaming, focusing on the potential of their products to serve as tools for emotional transformation rather than mere entertainment. Ultimately, TRIPP aims to help users achieve desired emotional states, fostering a unique mind-body connection through their innovative offerings.
Kindbody operates a health and tech company intended to offer fertility services and treatments for the modern woman. It offers a full range of services including intrauterine insemination, in-vitro fertilization, donor support, egg freezing, and embryo freezing, enabling women to improve their overall health and wellbeing.
Ellipsis Health, Inc. is a technology company based in San Francisco, California, that specializes in analytics solutions aimed at enhancing behavioral health. Founded in 2013, the company utilizes artificial intelligence to analyze patient speech and clinical data, enabling the prediction of health and well-being. By developing affective computing tools, Ellipsis Health creates real-time behavioral health metrics for patients, allowing health systems to continuously screen for conditions such as depression. This approach provides a simple and cost-effective method for healthcare providers to identify at-risk patients and ensure they receive the necessary support.
Gilgamesh Pharmaceuticals, Inc. is a preclinical biotechnology company founded in 2019 and based in New York, focused on developing innovative psychotropic drugs aimed at treating mental illnesses. The company specializes in oral arylcyclohexylamine and psychedelic medicines designed to address neuropsychiatric conditions such as depression, anxiety, substance use disorders, and stress-related issues. By leveraging a combination of medicinal chemistry, neuroscience, and drug development expertise, Gilgamesh Pharmaceuticals is committed to creating novel chemical entities that can effectively aid patients suffering from central nervous system disorders, thereby enhancing their recovery process.
Beckley Psytech Limited manufactures psychedelic drug for treating psychiatric and neurological diseases. Beckley Psytech Limited was formerly known as Beckley Psychedelics Limited and changed its name to Beckley Psytech Limited in May 2020. The company was founded in 2014 and is based in Oxford, United Kingdom.
LivNao Technologies leverages deep learning to detect changes in mental health before it affects performance and productivity. Their deep learning model can detect deviation before performance is affected by collecting data passively. When they have detected a change in mental health, they nudge individuals with an intervention based on their health plan. LivNao is committed to creating a healthier, happier, and more productive world, in the way they know best using data. LivNao is also 100% HIPAA-compliant. It was based in Vancouver, Canada.
Courage Therapeutics is a research organization that develops new medicines for eating disorders. The company was founded in 2019 and is headquartered in Newton, Massachusetts.
ATAI Life Sciences AG is a biotech company based in Munich, Germany, with additional offices in Berlin and London. Founded in 2018, ATAI focuses on developing innovative treatments for mental health disorders. The company utilizes a decentralized, technology-driven platform model to efficiently address significant unmet medical needs in this field. By integrating expertise and resources across its portfolio, ATAI aims to accelerate the development of therapies that can create meaningful changes in mental health treatment. Through its commitment to evidence-based solutions, ATAI seeks to improve the lives of millions affected by mental health issues.
NeuroFlow, Inc. is a digital health company that offers a cloud-based platform designed to enhance access to behavioral health services and improve patient engagement across various care settings. Founded in 2016 and headquartered in Philadelphia, Pennsylvania, NeuroFlow provides tools for remote patient monitoring and integrates behavioral health into practices such as psychology, primary care, and pain management. The platform is HIPAA-compliant and utilizes evidence-based practices to help healthcare providers track and assess patients' mental health, aiming to increase engagement and compliance. NeuroFlow serves a diverse range of clients, including healthcare practices, hospitals, health systems, health plans, and individuals. The company has established strategic partnerships with organizations such as Mental Health America and the National Science Foundation to further its mission of optimizing mental wellness and improving health outcomes.
ATAI Life Sciences AG is a biotech company based in Munich, Germany, with additional offices in Berlin and London. Founded in 2018, ATAI focuses on developing innovative treatments for mental health disorders. The company utilizes a decentralized, technology-driven platform model to efficiently address significant unmet medical needs in this field. By integrating expertise and resources across its portfolio, ATAI aims to accelerate the development of therapies that can create meaningful changes in mental health treatment. Through its commitment to evidence-based solutions, ATAI seeks to improve the lives of millions affected by mental health issues.
Osmind Inc. specializes in developing healthcare software tailored for mental health providers and their patients, particularly focusing on treatment-resistant mental health conditions. Founded in 2020 and based in California, the company aims to enhance clinical care and streamline workflows for providers through its innovative software solutions. Osmind's tools not only facilitate improved patient care but also support the advancement of novel therapeutics, precision diagnostics, and care management programs. The company's mission is to increase patient access to effective mental health treatments that can succeed where traditional therapies may not.
Gilgamesh Pharmaceuticals, Inc. is a preclinical biotechnology company founded in 2019 and based in New York, focused on developing innovative psychotropic drugs aimed at treating mental illnesses. The company specializes in oral arylcyclohexylamine and psychedelic medicines designed to address neuropsychiatric conditions such as depression, anxiety, substance use disorders, and stress-related issues. By leveraging a combination of medicinal chemistry, neuroscience, and drug development expertise, Gilgamesh Pharmaceuticals is committed to creating novel chemical entities that can effectively aid patients suffering from central nervous system disorders, thereby enhancing their recovery process.
Field Trip Health, Inc. providing simple, evidence-based therapies for healing and heightening engagement with the world.
Mindstrong Inc., operating as Mindstrong Health, focuses on remote patient monitoring and mental health symptom assessment through its innovative application. The platform utilizes AI-powered digital biomarker technology to enable users to monitor their mental health symptoms continuously and objectively. Mindstrong offers a range of services, including cognitive behavioral therapy, crisis management, and psychoeducation, delivered through structured messaging sessions. The company develops comprehensive care pathways that integrate passively collected data on cognitive function and mood, enhancing patient engagement through telehealth solutions. Founded in 2013 and based in Mountain View, California, Mindstrong collaborates with various stakeholders, including pharmaceutical companies, healthcare providers, and academic institutions, to advance medical innovation and improve healthcare delivery.
Foresight is a technology-enabled psychiatry and therapy services company. We directly employ psychiatrists, therapists, psychiatric nurse practitioners to treat patients in our offices. Our team of software and biomedical engineers create technology alongside our providers to revolutionize the care we provide.
ATAI Life Sciences AG is a biotech company based in Munich, Germany, with additional offices in Berlin and London. Founded in 2018, ATAI focuses on developing innovative treatments for mental health disorders. The company utilizes a decentralized, technology-driven platform model to efficiently address significant unmet medical needs in this field. By integrating expertise and resources across its portfolio, ATAI aims to accelerate the development of therapies that can create meaningful changes in mental health treatment. Through its commitment to evidence-based solutions, ATAI seeks to improve the lives of millions affected by mental health issues.
Foresight is a technology-enabled psychiatry and therapy services company. We directly employ psychiatrists, therapists, psychiatric nurse practitioners to treat patients in our offices. Our team of software and biomedical engineers create technology alongside our providers to revolutionize the care we provide.
Pray.com is a social impact company based in the United States that focuses on fostering faith and community through its mobile application and website. The platform enables users to create and share prayers, access daily prayer plans, and engage with inspirational content from faith leaders and their peers. By offering faith-based social networking tools, Pray.com aims to cultivate a supportive environment where individuals can connect, grow their faith, and leave a positive legacy. The company's mission emphasizes the importance of empathy and community support, appealing to a diverse audience that includes both traditional prayer practitioners and those who seek to promote compassion and understanding in the world.